ahlam1399
07-18-2016, 07:43 PM
BRIEF-ANI Pharmaceuticals an**unces FDA approval, launch of Nilutamide tablets
* ANI Pharmaceuticals an**unces FDA approval and immediatelaunch of Nilutamide tablets, the first generic competitor toNilandronhttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=ssiEUK8L9nY:DKgNa9EzyTI:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=ssiEUK8L9nY:DKgNa9EzyTI:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=ssiEUK8L9nY:DKgNa9EzyTI:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=ssiEUK8L9nY:DKgNa9EzyTI:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=ssiEUK8L9nY:DKgNa9EzyTI:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/ssiEUK8L9nY
* ANI Pharmaceuticals an**unces FDA approval and immediatelaunch of Nilutamide tablets, the first generic competitor toNilandronhttp://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=ssiEUK8L9nY:DKgNa9EzyTI:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=ssiEUK8L9nY:DKgNa9EzyTI:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=ssiEUK8L9nY:DKgNa9EzyTI:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=ssiEUK8L9nY:DKgNa9EzyTI:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=ssiEUK8L9nY:DKgNa9EzyTI:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/ssiEUK8L9nY